# Exelan Pharmaceuticals Inc

Source page: https://datainside.ai/companies/exelan-pharmaceuticals-inc-e19d06b85326

## Facts
- Legal name: EXELAN PHARMACEUTICALS INC
- Unique Entity ID (UEI): FYZXNHSQTMG8
- Country: United States
- Federal contract awards: 8, $13,129,293 obligated (2026-05-06 to 2026-10-07)

## Top customers
- Department of Veterans Affairs: 8 awards, $13,129,293

## Industries (NAICS)
- 325412 PHARMACEUTICAL PREPARATION MANUFACTURING: 8 awards, $13,129,293

## Latest awards
| Award | Agency | NAICS | Obligated | Date | Source |
|---|---|---|---|---|---|
| 36C26227N0055 | Department of Veterans Affairs | 325412 | $750,000 | 2026-10-07 | https://www.usaspending.gov/award/CONT_AWD_36C26227N0055_3600_36C26226A0006_3600 |
| 36C26027F0007 | Department of Veterans Affairs | 325412 | $789,600 | 2026-10-01 | https://www.usaspending.gov/award/CONT_AWD_36C26027F0007_3600_36F79720D0227_3600 |
| 36C24827N0053 | Department of Veterans Affairs | 325412 | $2,469,522 | 2026-10-01 | https://www.usaspending.gov/award/CONT_AWD_36C24827N0053_3600_36F79720D0227_3600 |
| 36C26027F0002 | Department of Veterans Affairs | 325412 | $1,510,593 | 2026-10-01 | https://www.usaspending.gov/award/CONT_AWD_36C26027F0002_3600_36F79720D0227_3600 |
| 36C24526N0871 | Department of Veterans Affairs | 325412 | $1,715,730 | 2026-09-18 | https://www.usaspending.gov/award/CONT_AWD_36C24526N0871_3600_36F79720D0227_3600 |
| 36C24226N0564 | Department of Veterans Affairs | 325412 | $3,130,958 | 2026-05-29 | https://www.usaspending.gov/award/CONT_AWD_36C24226N0564_3600_36F79720D0227_3600 |
| 36C25926F0197 | Department of Veterans Affairs | 325412 | $1,844,059 | 2026-05-14 | https://www.usaspending.gov/award/CONT_AWD_36C25926F0197_3600_36F79720D0227_3600 |
| 36C26026F0261 | Department of Veterans Affairs | 325412 | $918,831 | 2026-05-06 | https://www.usaspending.gov/award/CONT_AWD_36C26026F0261_3600_36F79720D0227_3600 |

Data: DataInside, from USAspending.gov awards; every fact links to its source on the page. Award totals are federal obligations, not company revenue.